PSNL

SEC filing PSNL Receives Expanded Medicare Coverage for NeXT Personal Test in Triple-Negative and HER2+ Breast Cancer Treatment Monitoring

12d ago

News Personalis (PSNL) Q2 Revenue Falls 24%

14d ago

News Why Tempus AI Stock Skyrocketed Nearly 22% Today

14d ago

News Personalis outlines 170% clinical test volume growth target for 2026 as reimbursement and MRD strategy accelerate

95d ago

Insider trade Purchase by Tempus AI, Inc.

104d ago

Insider trade Sale by Aaron Tachibana

104d ago

News Personalis rises on Medicare coverage for NeXT Personal cancer test

112d ago

News Cathie Wood's weekly update: buys Broadcom, AMD; sells Tesla, Illumina

134d ago

News Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL)

154d ago

Scanner Unusual volume (z=5.0)

160d ago

Scanner Unusual volume (z=5.3)

162d ago

Scanner Unusual volume (z=5.3)

163d ago

Scanner Unusual volume (z=5.3)

164d ago

Scanner Unusual volume (z=5.4)

169d ago

Scanner Unusual volume (z=5.4)

170d ago

Scanner Unusual volume (z=5.4)

171d ago